Pfizer Hematology

 

Hodgkin Lymphoma
19:25

Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

FEATURING Andrew Ip
  • July 25, 2024
19:39

Pfizer Hematology

The First Treatment Choice Matters

FEATURING Andrew Ip
  • July 25, 2024
19:39

Pfizer Hematology

Making the First Chance Count: Manuel

FEATURING Andrew Ip
  • July 25, 2024
18:30

Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage III/IV Classical Hodgkin Lymphoma

FEATURING Andrew Whiteley
  • July 25, 2024